heterozygous FECH mutations which are not the typical genetic findings in North American EPP patients. Conclusions: This is a first reported case of EPP with advanced liver disease in infancy. The compound heterozygote FECH mutations in this case likely account for the early onset severe hepatopathy. While bone marrow transplant offers a cure for EPP its timing and tolerability deserves consideration in relation to the severity of liver disease and need for liver transplantation.
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